As we expected, SPRY4-IT1 acts as a ceRNA for miR-101-3p in CCA, and binding with miR-101-3p releases its inhibition of EZH2 mRNA, resulting in elevated EZH2 protein levels. Here, EZH2 is linked to cholangiocarcinoma.